Terms: = Prostate cancer AND LMO1, RBTN1, 4004, ENSG00000166407, P25800, RHOM1, TTG1
3 results:
1. LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types.
Zhao GF; Du LQ; Zhang L; Jia YC
Chin Med J (Engl); 2021 Apr; 134(9):1017-1030. PubMed ID: 33870932
[TBL] [Abstract] [Full Text] [Related]
2. Upregulated lmo1 in prostate cancer acts as a novel coactivator of the androgen receptor.
Gu H; Liu T; Cai X; Tong Y; Li Y; Wang C; Li F
Int J Oncol; 2015 Dec; 47(6):2181-7. PubMed ID: 26459575
[TBL] [Abstract] [Full Text] [Related]
3. Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy.
Pilepich MV; John MJ; Krall JM; McGowan D; Hwang YS; Perez CA
Am J Clin Oncol; 1990 Dec; 13(6):461-4. PubMed ID: 2146872
[TBL] [Abstract] [Full Text] [Related]
